Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place
Save the Date!

2018 Unrivalled Speaker Faculty

To find out what each speaker will be sharing their wisdom on, download your copy of the brochure here.

Is your company being represented by a speaker? Get in touch for the company rate.


Joaquin Duato

Joaquin Duato

WorldWide Chairman, Pharmaceuticals, Johnson & Johnson

Read more

More information coming soon...

Sebastian Guth

Sebastian Guth

Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals

Read more

Sebastian Guth is Executive Vice President and Chief Marketing Officer for Bayer Pharmaceuticals. In addition, he is responsible for the P&L and entire operations of Bayer's global Radiology Business Unit. Mr. Guth is a member of the Pharmaceuticals Executive Committee and Global Pharmaceuticals Development Committee.

Based in Berlin, Germany, Mr. Guth oversees global product strategy, marketing, market access and marketing operations for Bayer’s prescription pharmaceuticals portfolio. Bayer Pharmaceuticals’ portfolio focuses on highly innovative new launches and a broad range of established products for cardiology and women’s healthcare as well as for specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Radiology Business Unit develops and commercializes diagnostic imaging equipment together with the necessary contrast agents.

Before assuming his current role at Bayer Pharmaceuticals in October 2015, Mr. Guth was Chief Marketing Officer for Bayer’s General Medicine Business. Previously he served as President & Chief Executive Officer of Bayer Yakuhin Ltd., Osaka, leading Bayer’s healthcare business in Japan.

Sebastian Guth’s professional career in the pharmaceuticals industry started in 2001 with Schering where he was Special Projects Leader for Asia and the Middle East. This led to his transfer to Schering Singapore Pte. as Managing Director for Malaysia, Singapore, and Vietnam the following year. Returning to Berlin in 2005, Mr. Guth was appointed Head of Strategy and Business Development for Schering’s European business. Following Bayer’s acquisition of Schering in 2006, he acted as Chief Executive Officer of Bayer Turk, Istanbul, and was Senior Representative of the Bayer Group in Turkey from 2007, until his transfer to Japan in early 2011.

Born in 1974, Sebastian Guth is married and has three children.

Christi Shaw

Christi Shaw

Senior Vice President & President, Lilly Bio Medicines

Read more

More information coming soon...

Rob Koremans

Rob Koremans

CEO & President, TEVA Specialty Medicines

Read more

Dr. Rob Koremans has led Teva’s Global Specialty Medicines business as President and CEO since 2013.

A member of Teva’s Executive Committee (TEC), Rob provides input into the overall direction of the Company, and reports to the CEO. He leads an organization of 3000+ employees with 15 direct reports in key leadership positions. Since joining Teva, he has established four global therapeutic areas within Teva’s branded business unit, including CNS, Respiratory, Oncology and Women’s Health.

Rob previously served as President and CEO of Teva Pharmaceuticals Europe beginning in 2012, and established the management structure for branded products in Europe. This included the acquisition of exclusive rights to Copaxone from Sanofi, driving branded product sales which increased by 25%, and the launch of 6 new branded products.  In this role, he also focused on the development of PGT, Teva’s joint venture with P&G on its OTC business, achieving 20% growth in sales and operating profit in 2012.

Prior to joining Teva, Rob held senior executive positions at Sanofi, the Elsevier Group, Cryo-Save, Johnson & Johnson (Cilag AG), the Serono Group and Grunenthal GmbH. He received a medical degree from the Erasmus University of Rotterdam in 1988 and earned an executive MBA from Babson College in Massachusetts.  

A native of the Netherlands, he is married to a physician and is the father of three daughters. He brings his dedication and commitment as a physician and as business leader to a company that is focused on improving health. In leading his organization, Rob puts the patient at the center, as well as in his life personally.

Paul Perrault

Paul Perrault

CEO, CSL Limited

Read more

More information coming soon...

Giles Platford

Giles Platford

President, Europe and Canada Business Unit, Takeda

Read more

More information coming soon...

andrin_oswald

Andrin Oswald

Director – Life Sciences Partnerships, Global Health, Gates Foundation

Read more

More information coming soon...

Kabir Nath

Kabir Nath

President & CEO, Otsuka USA

Read more

More information coming soon...

julie_gerberding

Julie Gerberding

EVP & Chief Patient Officer, MSD

Read more

More information coming soon...

nathalie_moll

Nathalie Moll

Director General, EFPIA

Read more

More information coming soon...

Click here to download the brochure and receive the full speaker line-up & Agenda

Milind Kamkolkar

Milind Kamkolkar

Chief Data Officer, Sanofi

Read more

More information coming soon...

Mark Mallon

Mark Mallon

EVP, Global Product and Portfolio Strategy, AstraZeneca

Read more

More information coming soon...

Andrew Baum

Andrew Baum

Managing Director Global Head of Healthcare Research, Citi

Read more

More information coming soon...

Ameet Nathwani

Ameet Nathwani

EVP & Chief Medical Officer, Sanofi

Read more

More information coming soon...

William H. Carson

William H. Carson

President & CEO, Otsuka Pharmaceuticals Development & Commercialization, Inc.

Read more

More information coming soon...

Bahija Jallal

Bahija Jallal

Executive Vice-President, MedImmune

Read more

More information coming soon...

Alfredo Barón de Juan

Alfredo Barón de Juan

EVP Global Commercial Operations, Almirall

Read more

More information coming soon...

Dr. Carey Adams

Dr. Carey Adams

CEO, UICC

Read more

More information coming soon...

jean_luc_eisele

Jean-Luc Eiselé

CEO, World Heart Federation

Read more

More information coming soon...

Bryon Matthews

Bryon Matthews

President and CEO, Miller Heiman Group

Read more

More information coming soon...

Nolan Townsend

Nolan Townsend

Regional President, International Developed Markets, Pfizer

Read more

More information coming soon...

Peter Meeus

Peter Meeus

Head of Region Europe, Shire

Read more

More information coming soon...

Tal Zorman

Tal Zorman

Senior VP Leadership, Learning and Development, TEVA

Read more

More information coming soon...

Ryan Olohan

Ryan Olohan

National Industry Director, Google

Read more

More information coming soon...

Angela Hwang

Angela Hwang

General Manager and Global President Inflammation and Immunology Business, Pfizer

Read more

More information coming soon...

Lutz Bonacker

Lutz Bonacker

Senior Vice President and General Manager, Commercial Operations Europe, CSL Behring

Read more

More information coming soon...

Patrik Grandits

Patrik Grandits

Head Commercial Operations Oncology Europe, Daiichi Sankyo

Read more

More information coming soon...

Eric Pardell

Eric Pardell

Global Head, Leadership Development & Centres of Excellence Integrations, Novartis

Read more

More information coming soon...

Ulrich Betz

Ulrich Betz

Vice President Innovation, Merck

Read more

More information coming soon...

Arnaud Lefevre

Arnaud Lefevre

Head of Operations, Northern Europe, UCB

Read more

More information coming soon...

Click here to download the brochure and receive the full speaker line-up & Agenda

Geoff Rollason

Geoff Rollason

Patient Experience and Services Director, Pfizer

Read more

More information coming soon...

Thomas Kerscher

Thomas Kerscher

Global Head Patient and Customer Excellence, Shire

Read more

More information coming soon...

Alvaro Herreros

Alvaro Herreros

Vice President - Global Neuroscience Franchise Head, Shire

Read more

More information coming soon...

Markus Kosch

Markus Kosch

Vice President Oncology Portfolio, Europe, Japan & Developed Asia, Pfizer

Read more

More information coming soon...

Rafael Ramon

Rafael Ramon

Customer Engagement Excellence Leader EEMEA, Roche

Read more

More information coming soon...

Jens Thiedemann

Jens Thiedemann

Head of Marketing Cardiovascular Europe, Executive Director, Daiichi Sankyo

Read more

More information coming soon...

Cesar Concepcion

Cesar Concepcion

General Manager and CPO Head Spain, Novartis

Read more

More information coming soon...

Mark Milton Edwards

Mark Milton Edwards

Global Commercial Senior Director, TEVA

Read more

More information coming soon...

Lisa Huse

Lisa Huse

General Manager, Spain, Roche Diabetes Care

Read more

More information coming soon...

Georgina Rizik

Georgina Rizik

Global Commercial Head, Oncology Franchise, Boehringer-Ingelheim

Read more

More information coming soon...

Gerwin Winter

Gerwin Winter

GM & VP – Germany, Celgene

Read more

More information coming soon...

Christian Hansen

Christian Hansen

Vice President Commercial Excellence, AstraZeneca

Read more

More information coming soon...

Melanie Capewell

Melanie Capewell

Group Head Commercial Development, SYNLAB International

Read more

More information coming soon...

Click here to download the brochure and receive the full speaker line-up & Agenda

jean_luc_eisele

Jean-Luc Eiselé

CEO, World Heart Federation

Read more

More information coming soon...

Aagjie Leven

Aagjie Leven

Secretary General, EUFAMI

Read more

More information coming soon...

pisana_ferrari

Pisana Ferrari

CEO, European Pulmonary Hypertension Association

Read more

More information coming soon...

Carmen Auste

Carmen Auste

Chair, Childhood Cancer International;
Founder, Cancer Warriors Foundation Inc

Read more

More information coming soon...

Ramona Kanters-Burgmans

Ramona Kanters-Burgmans

Director, OPEN

Read more

More information coming soon...

Astrid Wijngaarden

Astrid Wijngaarden

Patient

Read more

More information coming soon...

Monique van Bekkum

Monique van Bekkum

Mentor Coach, 365 Dagen Succesvol

Read more

More information coming soon...

Julian Noji

Julian Noji

Patient

Read more

More information coming soon...

Joaquin Duato

Joaquin Duato

WorldWide Chairman, Pharmaceuticals, Johnson & Johnson

Read more

More information coming soon...

Sebastian Guth

Sebastian Guth

Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals

Read more

Sebastian Guth is Executive Vice President and Chief Marketing Officer for Bayer Pharmaceuticals. In addition, he is responsible for the P&L and entire operations of Bayer's global Radiology Business Unit. Mr. Guth is a member of the Pharmaceuticals Executive Committee and Global Pharmaceuticals Development Committee.

Based in Berlin, Germany, Mr. Guth oversees global product strategy, marketing, market access and marketing operations for Bayer’s prescription pharmaceuticals portfolio. Bayer Pharmaceuticals’ portfolio focuses on highly innovative new launches and a broad range of established products for cardiology and women’s healthcare as well as for specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Radiology Business Unit develops and commercializes diagnostic imaging equipment together with the necessary contrast agents.

Before assuming his current role at Bayer Pharmaceuticals in October 2015, Mr. Guth was Chief Marketing Officer for Bayer’s General Medicine Business. Previously he served as President & Chief Executive Officer of Bayer Yakuhin Ltd., Osaka, leading Bayer’s healthcare business in Japan.

Sebastian Guth’s professional career in the pharmaceuticals industry started in 2001 with Schering where he was Special Projects Leader for Asia and the Middle East. This led to his transfer to Schering Singapore Pte. as Managing Director for Malaysia, Singapore, and Vietnam the following year. Returning to Berlin in 2005, Mr. Guth was appointed Head of Strategy and Business Development for Schering’s European business. Following Bayer’s acquisition of Schering in 2006, he acted as Chief Executive Officer of Bayer Turk, Istanbul, and was Senior Representative of the Bayer Group in Turkey from 2007, until his transfer to Japan in early 2011.

Born in 1974, Sebastian Guth is married and has three children.

Christi Shaw

Christi Shaw

Senior Vice President & President, Lilly Bio Medicines

Read more

More information coming soon...

Rob Koremans

Rob Koremans

CEO & President, TEVA Specialty Medicines

Read more

Dr. Rob Koremans has led Teva’s Global Specialty Medicines business as President and CEO since 2013.

A member of Teva’s Executive Committee (TEC), Rob provides input into the overall direction of the Company, and reports to the CEO. He leads an organization of 3000+ employees with 15 direct reports in key leadership positions. Since joining Teva, he has established four global therapeutic areas within Teva’s branded business unit, including CNS, Respiratory, Oncology and Women’s Health.

Rob previously served as President and CEO of Teva Pharmaceuticals Europe beginning in 2012, and established the management structure for branded products in Europe. This included the acquisition of exclusive rights to Copaxone from Sanofi, driving branded product sales which increased by 25%, and the launch of 6 new branded products.  In this role, he also focused on the development of PGT, Teva’s joint venture with P&G on its OTC business, achieving 20% growth in sales and operating profit in 2012.

Prior to joining Teva, Rob held senior executive positions at Sanofi, the Elsevier Group, Cryo-Save, Johnson & Johnson (Cilag AG), the Serono Group and Grunenthal GmbH. He received a medical degree from the Erasmus University of Rotterdam in 1988 and earned an executive MBA from Babson College in Massachusetts.  

A native of the Netherlands, he is married to a physician and is the father of three daughters. He brings his dedication and commitment as a physician and as business leader to a company that is focused on improving health. In leading his organization, Rob puts the patient at the center, as well as in his life personally.

Paul Perrault

Paul Perrault

CEO, CSL Limited

Read more

More information coming soon...

Giles Platford

Giles Platford

President, Europe and Canada Business Unit, Takeda

Read more

More information coming soon...

andrin_oswald

Andrin Oswald

Director – Life Sciences Partnerships, Global Health, Gates Foundation

Read more

More information coming soon...

Kabir Nath

Kabir Nath

President & CEO, Otsuka USA

Read more

More information coming soon...

julie_gerberding

Julie Gerberding

EVP & Chief Patient Officer, MSD

Read more

More information coming soon...

nathalie_moll

Nathalie Moll

Director General, EFPIA

Read more

More information coming soon...

Click here to download the brochure and receive the full speaker line-up & Agenda

Milind Kamkolkar

Milind Kamkolkar

Chief Data Officer, Sanofi

Read more

More information coming soon...

Mark Mallon

Mark Mallon

EVP, Global Product and Portfolio Strategy, AstraZeneca

Read more

More information coming soon...

Andrew Baum

Andrew Baum

Managing Director Global Head of Healthcare Research, Citi

Read more

More information coming soon...

Ameet Nathwani

Ameet Nathwani

EVP & Chief Medical Officer, Sanofi

Read more

More information coming soon...

William H. Carson

William H. Carson

President & CEO, Otsuka Pharmaceuticals Development & Commercialization, Inc.

Read more

More information coming soon...

Bahija Jallal

Bahija Jallal

Executive Vice-President, MedImmune

Read more

More information coming soon...

Alfredo Barón de Juan

Alfredo Barón de Juan

EVP Global Commercial Operations, Almirall

Read more

More information coming soon...

Dr. Carey Adams

Dr. Carey Adams

CEO, UICC

Read more

More information coming soon...

jean_luc_eisele

Jean-Luc Eiselé

CEO, World Heart Federation

Read more

More information coming soon...

Bryon Matthews

Bryon Matthews

President and CEO, Miller Heiman Group

Read more

More information coming soon...

Nolan Townsend

Nolan Townsend

Regional President, International Developed Markets, Pfizer

Read more

More information coming soon...

Peter Meeus

Peter Meeus

Head of Region Europe, Shire

Read more

More information coming soon...

Tal Zorman

Tal Zorman

Senior VP Leadership, Learning and Development, TEVA

Read more

More information coming soon...

Ryan Olohan

Ryan Olohan

National Industry Director, Google

Read more

More information coming soon...

Angela Hwang

Angela Hwang

General Manager and Global President Inflammation and Immunology Business, Pfizer

Read more

More information coming soon...

Lutz Bonacker

Lutz Bonacker

Senior Vice President and General Manager, Commercial Operations Europe, CSL Behring

Read more

More information coming soon...

Patrik Grandits

Patrik Grandits

Head Commercial Operations Oncology Europe, Daiichi Sankyo

Read more

More information coming soon...

Eric Pardell

Eric Pardell

Global Head, Leadership Development & Centres of Excellence Integrations, Novartis

Read more

More information coming soon...

Ulrich Betz

Ulrich Betz

Vice President Innovation, Merck

Read more

More information coming soon...

Arnaud Lefevre

Arnaud Lefevre

Head of Operations, Northern Europe, UCB

Read more

More information coming soon...

Click here to download the brochure and receive the full speaker line-up & Agenda

Geoff Rollason

Geoff Rollason

Patient Experience and Services Director, Pfizer

Read more

More information coming soon...

Thomas Kerscher

Thomas Kerscher

Global Head Patient and Customer Excellence, Shire

Read more

More information coming soon...

Alvaro Herreros

Alvaro Herreros

Vice President - Global Neuroscience Franchise Head, Shire

Read more

More information coming soon...

Markus Kosch

Markus Kosch

Vice President Oncology Portfolio, Europe, Japan & Developed Asia, Pfizer

Read more

More information coming soon...

Rafael Ramon

Rafael Ramon

Customer Engagement Excellence Leader EEMEA, Roche

Read more

More information coming soon...

Jens Thiedemann

Jens Thiedemann

Head of Marketing Cardiovascular Europe, Executive Director, Daiichi Sankyo

Read more

More information coming soon...

Cesar Concepcion

Cesar Concepcion

General Manager and CPO Head Spain, Novartis

Read more

More information coming soon...

Mark Milton Edwards

Mark Milton Edwards

Global Commercial Senior Director, TEVA

Read more

More information coming soon...

Lisa Huse

Lisa Huse

General Manager, Spain, Roche Diabetes Care

Read more

More information coming soon...

Georgina Rizik

Georgina Rizik

Global Commercial Head, Oncology Franchise, Boehringer-Ingelheim

Read more

More information coming soon...

Gerwin Winter

Gerwin Winter

GM & VP – Germany, Celgene

Read more

More information coming soon...

Christian Hansen

Christian Hansen

Vice President Commercial Excellence, AstraZeneca

Read more

More information coming soon...

Melanie Capewell

Melanie Capewell

Group Head Commercial Development, SYNLAB International

Read more

More information coming soon...

Click here to download the brochure and receive the full speaker line-up & Agenda

jean_luc_eisele

Jean-Luc Eiselé

CEO, World Heart Federation

Read more

More information coming soon...

Aagjie Leven

Aagjie Leven

Secretary General, EUFAMI

Read more

More information coming soon...

pisana_ferrari

Pisana Ferrari

CEO, European Pulmonary Hypertension Association

Read more

More information coming soon...

Carmen Auste

Carmen Auste

Chair, Childhood Cancer International;
Founder, Cancer Warriors Foundation Inc

Read more

More information coming soon...

Ramona Kanters-Burgmans

Ramona Kanters-Burgmans

Director, OPEN

Read more

More information coming soon...

Astrid Wijngaarden

Astrid Wijngaarden

Patient

Read more

More information coming soon...

Monique van Bekkum

Monique van Bekkum

Mentor Coach, 365 Dagen Succesvol

Read more

More information coming soon...

Julian Noji

Julian Noji

Patient

Read more

More information coming soon...

Keep updated with the full agenda and speaker line-up here

Full agenda | Speaker faculty | Group discounts